Weight Loss Drugs: Bone & Muscle Risks
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Weight Loss Drugs: Bone & Muscle Risks
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Weight loss drugs, like semaglutide and tirzepatide, based on gut hormones, are effective but may cause significant loss of muscle and bone mass, impacting long-term health. This loss stems from increased muscle protein breakdown and reduced bone stress. To mitigate these risks, individuals should increase protein intake, engage in resistance training, and maintain regular physical activity. While the long-term effects are still being studied, combining medication with lifestyle changes is currently the best approach.
keepSave to notecopy_all
docsAdd noteaudio_magic_eraserAudio OverviewschoolBriefing doc
Pas encore de commentaire